A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis With or Without Mesalamine [mesalazine].
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2012
At a glance
- Drugs HMPL 004; Mesalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 03 May 2012 EudraCT reports trial status as discontinued and inclusion-exclusion criteria amended.
- 28 Apr 2012 Additional trial location added as reported by European Clinical Trials Database.
- 28 Apr 2012 New source identified and integrated (EudraCT2007-005166-12: European Clinical Trials Database)